Horizon Ridge Limited holds 499,424 Class A ordinary shares of Universe Pharmaceuticals, representing 9.97% of the class. The ownership notice matters to investors because it identifies a sizable Shareholder while stating the securities were not acquired to change or influence control, apart from activities tied solely to a nomination.

Key Highlights

  • Horizon Ridge Limited reported ownership of 499,424 Class A ordinary shares, representing 9.97% of the class.
  • Horizon Ridge Limited and Shan Xie executed a joint filing agreement on September 1, 2026.
  • Horizon Ridge Limited holds 499,424 Class A ordinary shares of Universe Pharmaceuticals.

Universe Pharmaceuticals INC (NASDAQ: UPC) has a 9.97% shareholder in Horizon Ridge Limited, which holds 499,424 Class A ordinary shares. Shan Xie wholly owns and controls Horizon Ridge Limited.

499,424 Class A Shares

The reported position consists of 499,424 Class A ordinary shares held directly by Horizon Ridge Limited. Shan Xie is also identified with the same 499,424-share position because of her ownership and control of the British Virgin Islands company. Horizon Ridge Limited and Shan Xie are each listed with 9.97% ownership of the class.

Passive Ownership Position

It also states that the securities were not acquired or held in connection with a transaction having the purpose or effect of changing or influencing control of the issuer. The certification includes an exception for activities solely connected with a nomination under § 240.14a-11. The filing identifies the Horizon Ridge position as passive.

Horizon Ridge And Shan Xie

Horizon Ridge Limited is a Limited Liability company formed in the British Virgin Islands. Its listed address is the Vistra Corporate Services Centre in Road Town, Tortola, while Shan Xie is listed at an address on Hutai Road in Shanghai. Horizon Ridge Limited and Shan Xie agreed to file jointly with respect to Universe Pharmaceuticals’ Class A ordinary shares, and both signed the agreement on September 1, 2026.